Risperdal contains risperidone, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. It is used to treat schizophrenia and acute mania, or mixed episodes of bipolar disorders and autism spectrum disorders in children and adolescents FDA approval: Risperdal was first approved by the Food and Drug Administration (FDA) to treat schizophrenia in 1993. 2003: Short-term treatment of bipolar I disorder in adults. 2006: Treatment of irritability associated with spectrum disorders in children and adolescents 5 to 16 years old. 2007: Schizophrenia in adolescents ages 13 to 17 and short-term treatment of bipolar I disorder in children and adolescents ages 10 to 17. Lawsuit Focus – Drug injury. The drug is also used “off label” for attention deficit hyperactivity disorder (ADHD), anxiety, sleep difficulties and depression.
Case Evaluation Criteria:
Matrix Sample Case Evaluation
1. Whether the patient was prescribed Risperdal?
2. Reason for prescription? Is the patient really in need of Risperdal? Is it an off label use?
3. Did the patient have any preexisting conditions, allergies or contraindications for the Risperdal drug?
4. Dosage and Intake details (to be included under pharmacy log) Critical Review of Physician Drug Prescription Details Pharmacy Dispensing Details Pharmacy Refill Details Details of Pharmacy Dispensing Details are taken as Confirmatory
5. Did the patient develop Gynecomastia or lactation after Risperdal intake?
6. When and where was the injury diagnosed?
7. Treatment/management – Such as liposuction, Operative procedure (Mastectomy), indications, complications.
8. Follow-up visits for Surgical treatment/management
10. Any recurrence of breast growth?
11. Any prior significant history?